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ABSTRACT: Coarse-grained molecular dynamics provides a means for simulating the
assembly and interactions of macromolecular complexes at a reduced level of
representation, thereby allowing both longer timescale and larger sized simulations.
Here, we describe an enhanced fragment-based protocol for converting macromolecular
complexes from coarse-grained to atomistic resolution, for further refinement and
analysis. While the focus is upon systems that comprise an integral membrane protein
embedded in a phospholipid bilayer, the technique is also suitable for membrane-
anchored and soluble protein/nucleotide complexes. Overall, this provides a method for
generating an accurate and well-equilibrated atomic-level description of a macro-
molecular complex. The approach is evaluated using a diverse test set of 11 system
configurations of varying size and complexity. Simulations are assessed in terms of
protein stereochemistry, conformational drift, lipid/protein interactions, and lipid
dynamics.
■ INTRODUCTION
Membrane proteins are fundamental to life. They are the gate
keepers into and out of a cell and critical receptors for
transmitting signals across cellular membranes. In the majority
of organisms, they comprise ∼25% of genes, and from a
pharmaceutical perspective, they form the targets for roughly
half of all drugs.1−3 Structural determination of these proteins
has advanced considerably in the past decade, with improve-
ments to the protocols for X-ray diffraction and the advent of
atomic-resolution cryo-electron microscopy (cryo-EM) result-
ing in a total of over 5000 membrane protein structures, of
which there are more than 1000 unique proteins (see http://
memprotmd.bioch.ox.ac.uk/stats for the most recent data).4
Despite these improvements, the lipids in the surrounding
environment are frequently difficult to capture, either being
lost in the purification process, too diffuse to accurately
determine atomic coordinates,5 or difficult to assign as a
defined lipid type.
Molecular dynamics (MD) simulations provide an ideal tool
for capturing the lipid environment around these membrane
protein structures, as we have shown through our database of
all membrane-embedded structures, MemProtMD.4 The use of
coarse-grained (CG) modeling allows for the observation of
slow processes such as membrane bending and deformations,6
protein−lipid interactions,7,8 and association of soluble
proteins to bilayers.9 The simulation time required for these
events is generally beyond that afforded for conventional
atomistic simulations.10 CG-MD simulations enable a well-
configured springboard for studying, for example, molecular
and ionic transport, ligand binding, structural dynamics, and
lipid interactions of proteins.10,11 However, first, one must
translate the system from a CG representation to an atomic-
level description. A number of methods have been developed
for the conversion of a CG system to an atomistic one,
including, for example, a simulated annealing methodology,12 a
geometric-based backward protocol,13 machine learning
algorithms,14,15 and a previous iteration of the fragment-
based CG2AT approach.16 In all cases, the methodologies
permit serial multi-scale MD simulations.17
Here, we describe a complete reworking and enhancement
of our fragment-based approach, introducing an assortment of
new features, an increased level of flexibility, enhanced
scalability, and greatly improved interoperability. We apply
our method to a range of molecular systems, from biological
membranes to integral membrane proteins, lipid-modified
lipoproteins, and DNA-bound soluble proteins.
■ METHODS
Implementation and Database. To enable the con-
version of the CG system to an atomistic representation, the
stereochemistry of each bead and molecule must be
reintroduced. Various conversion methods have been
previously proposed to enable conversion of a CG system in
a de novo manner (see above). For CG2AT2, we implement a
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similar fragment-based methodology to the previous iteration
of CG2AT, in which small atomistic fragments containing all
the chemical and stereochemical information required are
rigidly aligned to each CG bead.
For CG2AT2, we have assembled a database of fragment
files that are related to the commonly used force fields, for
example, CHARMM,18 AMBER,19 GROMOS,20 and OPLS.21
To simplify the development and usability of the fragment
database, minimal information is required beyond the
atomistic fragments (Figure 1A) and an optional itp file (e.g.,
POPC.itp).
The fragment files are stored within a single-coordinate file,
where the residue is separated by bead names into fragments
(Figure 1A). The variable lengths and protonation states of
multimeric macromolecules such as proteins necessitate that
the topologies are generated on the fly using the GROMACS22
tool pdb2gmx. However, individual non-protein molecules, for
example, palmitoyl-oleoyl-phosphatidylcholine (POPC), can
use the supplied topology itp file in the database.
Additional information that cannot be retrieved from the itp
and/or force field files is supplied in a topology file. This
topology file contains four sections to aid the conversion. This
file details inter-residue connectivity, fragment groupings,
terminal residue information, and chiral groups (Figure 1B).
The chiral group section enables the appropriate stereo-
chemistry to be adhered to upon conversion. This can be aided
further by grouping atomistic fragments together, so that they
are structurally aligned as a single unit to the CG beads (Figure
1C). For polymers, that is, proteins, sugars, and nucleotides,
inter-residue connectivity makes sure that residues are
appropriately linked, and the terminal residue state options
apply appropriate charge states to the first and last residues.
An optional position restraint file for the non-protein
residues can also be included. Within the supplied database,
the position restraints are a harmonic potential of 50 kJ mol−1
nm−2 on the xyz axis. These restraints may be applied by
GROMACS during the equilibration and steering steps to
minimize deviation from the CG system.
Conversion Protocol. The conversion protocol of
CG2AT2 can be condensed into four core steps: conversion,
minimization, integration, and equilibration (Figure 1D).
Conversion. The initial conversion phase consists of
atomistic fragment fitting to the CG beads. Here, the atomistic
fragments are aligned by their center of mass to their respective
CG bead. The aligned coordinates are then rotated to
minimize bond distances with their adjacent connected
beads. In this manner, each fragment can be treated
individually with no knowledge of the surrounding atomistic
fragments (Figure 2A). To improve upon the initial
conversion, we have implemented a fragment-grouping system,
detailed in an optional topology file (Figure 1B), which allows
for multiple fragments to be treated as a single fragment, for
example, an amino acid side chain (Figure 1C). It is possible
within CG2AT2 to swap beads and residues using the flag
Figure 1. Workflow and database composition. (A) Fragment file for phenylalanine. Each fragment has a header containing the corresponding CG
bead name, for example, backbone [BB], side chain [SC1], and so on, followed by the atoms within the fragment. If the molecule is not processed
by pdb2gmx, then, the atom numbers should match the supplied topology itp file. (B) Topology file for phenylalanine. There are six sections within
the topology file: CONNECT details the connectivity of the backbone and should follow a four-column convention: bead name, associated atom
name, connected bead name, and numeric direction of the connected bead. GROUPS contain the fragment groupings, as shown in the (C)
“Grouped” section. N_TERMINAL and C_TERMINAL contain any non-standard atomistic termini for the residue. CHIRAL contains any
stereochemistry information present within the residue. This is described in the column format: central atom, atom to move, atom 1, atom 2, and
atom 3. (C) Graphical depiction of the grouped (left) and modular (right) methodologies implemented within CG2AT2, where atomistic
fragments are either grouped and aligned with their CG beads or aligned individually in a modular fashion. The conversion of phenylalanine is
shown. Here, the grouped approach improves the conversion quality. (D) Description of the conversion of CG to AT. Initially, CG2AT2 converts
the CG system in a de novo manner from the fragments supplied. If an atomistic protein structure is provided, this structure is aligned with the CG
coordinates, with the de novo protein coordinates steered to the aligned protein coordinates to remove clashes with surrounding atoms, for example,
lipids.
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-swap. This enables the user to undertake minor mutations, for
example, POPE to palmitoyl-oleoyl-phosphatidylglycerol
(POPG) during the conversion process.
Minimization. After a successful conversion, each molecule
type undergoes a single round of minimization by the steepest
descent algorithm. This corrects the majority of bond lengths
and angles and any steric clashes.
Integration. Following a successful build of each molecule
type, the system components are reintegrated and minimized.
In rare cases upon reintegration, it is possible for lipid tails to
be threaded through aromatic structures such as phenylalanine.
To detect these instances, abnormal bond lengths are used as
an indicator of a threaded molecule. Once identified, the two
atom groups connected via the abnormal bond are translated
by three times the normalized vector between the backbone of
the residue and the center of the two atom groups. This
translation is sufficient to circumvent the threaded residue. The
system is subsequently minimized to correct any distortions
and reassessed (Figure 2B).
Equilibration. There are a number of levels of equilibration
implemented by CG2AT2, depending on the required output.
In the simplest and fastest instance, a non-equilibrated
atomistic system may be produced by using the flag -o none.
This means that the system is only energy-minimized as part of
the conversion, following the reintegration of the complete
system. Beyond this, the default level of equilibration for
CG2AT2 is to relax the system with a 5 ps NVT simulation
with position restraints applied to the backbone Cα atoms of
the protein, if included.
Protein Conversion Types. To establish the atomistic
protein coordinates, CG2AT2 enables both a de novo protocol,
where the atoms are constructed from the CG beads, and/or
an aligned approach, where a supplied atomistic protein
structure is fitted with the CG protein coordinates. The
decision of which approach to use depends upon whether one
wishes to retain any protein conformational changes that have
arisen from the CG simulation. The de novo method is also
well suited to retain protein interactions with non-protein
groups such as lipids and minor conformational changes.
Conversely, if particular atomic interactions are important, for
example, the orientation of the backbone within the selectivity
filter of a potassium channel, or if the CG simulation is being
used to establish an optimal bilayer as a starting point for an
atomistic simulation, the aligned method should be used.
CG2AT2 allows for a range of conversion types for the user;
the choice of which to use depends upon the hypotheses being
addressed by the simulation. Upon successful conversion, a
RMSD value comparing the backbone of each CG monomer
to the converted atomistic protein is provided along with a
summary of the atomistic system.
The de novo method is reliant on the coordinates of the CG
beads. To improve the secondary structure, an additional
correction is applied to the amide bond, after the fragment
alignment. In this correction, the amide bond is aligned to the
cross-vector of the two proceeding backbone beads, as
originally outlined by Wassenaar et al.13 This enables the
majority of the backbone hydrogen bond network to be
recovered. Conversely, if a higher degree of similarity to the
atomistic input structure is required, the backbone hydrogen
bond network within the supplied atomistic structure is
mapped. This network is used as distance restraints to guide
the de novo NVT equilibration and thereby aid in the recovery
of the secondary structure lost during the CG simulation. This
allows the production of either an independent de novo or
Figure 2. Graphical depiction of the conversion of Martini’s POPC to CHARMM36 atomistic representation. (A) General conversion protocol
implemented with CG2AT2. Here, the individual fragments are aligned within each bead and rotated to minimize the distance between connecting
beads. Once aligned, the residue undergoes the first round of minimization. Hydrogens are hidden for clarity. (B) Disentanglement of a lipid tail
from the side chain of phenylalanine. If an abnormally long bond is detected after the initial minimization of the merged system, the two non-
hydrogen atoms and connected hydrogens are translated on a vector away from the threaded amino acid backbone. The system is then minimized
to correct the bond lengths between the adjusted atoms. (C) Depiction of alignments available for the conversion of CG to AT. Here, the user is
able to select whether to align the atomistic chains individually, grouped by the CG chain, in selective groups or as a single macromolecular unit.
Root mean square deviation (RMSD) measurements are highlighted: Cα against CG BB. (D) Flow chart of the alignment of individually supplied
atomistic chains. Here, LolB is created in the de novo manner depicted in the red cartoon. The supplied atomistic chains (colored blue) are aligned
to the CG BB beads. The missing residues highlighted during chain alignment are copied from the de novo structure and mapped onto the aligned
structure.
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guided de novo structure. The latter may be implemented using
the flag -disre and an input -a atomistic protein coordinate file
(Figure S1).
The aligned method requires a supplied atomistic structure,
using the -a flag, and builds upon the de novo conversion. With
the de novo method, the user is able to select the degree of
information taken from the CG system. CG2AT2 contains four
alignment methods for the supplied atomistic chains:
individual atomistic chains (default), user-defined grouped
atomistic chains, whole atomistic protein, or grouped based on
the CG subunits (Figure 2C). Initially, the supplied structure is
separated into individual chains, identified by a greater than 4
Å amide bond length. The amino acid sequence of each
atomistic chain is then indexed to the CG protein sequence.
Depending upon the choice of grouping, the atomistic
backbone is fitted to the CG model. If only a partial structure
is detected during the sequence alignment, CG2AT2 imple-
ments a hybrid build approach, that is, combining de novo and
aligned protein structures (Figure 2D). In this instance, any
residues missing from the input atomistic structure but within
the CG protein are incorporated from the de novo method.
This is particularly useful for adding flexible, unfolded residues
to a protein, for example, growing residues onto a core CG
protein to add lipoprotein tethers.23
The energy-minimized de novo non-hydrogen atoms are
steered onto the aligned protein coordinates generated by the
aforementioned structural alignment. The steering is under-
taken in a multi-step process of increasing harmonic restraints
for 2 ps each (100−10,000 kJ mol−1 nm−2). This methodology
preserves interactions between protein and non-protein
residues with minimal perturbation and compares favorably
with other embedding methodologies, such as g_membed,
alchembed, inflategro, and the original CG2AT,16,24−26 in
retaining protein−lipid interactions from CG. To minimize
non-protein molecule displacement during the steered MD, an
additional positional restraint is applied to the non-protein and
non-hydrogen atoms, as described by the supplied position
restraint file.
Macromolecular Systems. We tested CG2AT2 upon a
range of increasingly complex systems from plain lipid bilayers
to multi-membrane-spanning protein complexes. The systems
were all taken from ongoing projects within our research group
using a mixture of Martini versions 2.0,27 2.2,28,29 and 3.0
(beta).
For all CG Martini simulations, an elastic network of 1000
kJ mol−1 nm−2 was applied between all backbone beads
between 0.5 and 1 nm. Electrostatics were described using the
reaction field method, with a cutoff of 1.1 nm using the
potential shift modifier, and the van der Waals interactions
were shifted between 0.9 and 1.1 nm. The temperature and
pressure were kept constant throughout the simulation at 310
K and 1 bar, respectively, with protein, lipids, and water/ions
coupled separately to temperature baths by the V-rescale
method30 and a semi-isotropic Parrinello−Rahman barostat.31
In the atomistic simulations, electrostatics were described
using PME, with a cutoff of 1.2 nm, and the van der Waals
interactions were shifted between 1 and 1.2 nm. The TIP3P
water model was used; the water bond angles and distances
were constrained using SETTLE.32 All other bonds were
constrained using the LINCS algorithm.33 The production
simulations were run in an NPT ensemble with temperature V-
rescale coupling at 310 K with protein, lipids, and water/ions
coupled individually and semi-isotropic Parrinello−Rahman
barostat at 1 bar. All CGMD systems contain a salt
concentration of 0.15 M NaCl. After 1 μs of CGMD
simulation, the CG systems were converted to a CHARMM36
atomistic form. To access the stability of the CG2AT
conversions, the systems were equilibrated for 1 ns with
1000 kJ mol−1 nm2 position restraints applied to the Cα atoms
after their conversion. A further 100 ns unrestrained MD
simulation was then performed on each atomistic system. The
following systems are ordered by system size from small
(∼37,000 atoms) to large (>2,000,000 atoms).
System 1a POPC Membrane. A CG bilayer of 128
POPC lipids was solvated with 1682 Martini water beads with
a total system size of 3256 beads. By comparison, the
converted atomistic system has 37,830 atoms.
System 2a Mixed-Lipid Bilayer. A bilayer consisting of 80
POPC, 10 palmitoyl-oleoyl-phosphatidylserine (POPS), and
32 cholesterol (CHOL) molecules was solvated with 1778
Martini water beads, creating a total system size of 3170 beads.
The converted atomistic system has 36,362 atoms.
System 3SRY. The sex-determining region Y (SRY)
protein recognizes and binds to double-stranded nucleotides.
We used the Homo sapiens structure (PDB ID: 1J4634) to
create the CG representation and for CG2AT2 conversion.
The system consists of a CG tetrameric SRY with 13 DNA
base pairs, solvated with 18,661 Martini water beads, yielding a
system size of 4640 beads. The atomistic system contains
53,425 atoms.
System 4δ-Opioid. The class A G-protein-coupled
receptor (δ-opioid) activates the β-arrestin and G-protein
pathways in the central nervous system. We used the H. sapiens
structure (PDB ID: 4N6H35) to create the CG representation
and for CG2AT2 conversion. The system consists of a CG δ-
opioid and 237 POPC molecules solvated with 3743 Martini
water beads, yielding a system size of 7338 beads. The
converted atomistic system contains 82,569 atoms.
System 5Lgt. The lipoprotein diacylglyceryl transferase
(Lgt) transfers the diacylglyceryl group from a phospholipid to
the thiol group of a conserved cysteine residue of the
prolipoprotein. We used the Escherichia coli model (PDB ID:
5AZC36) to create the CG representation and for CG2AT2
conversion. The system consists of a CG Lgt, 74 POPG, and
290 palmitoyl-oleoyl-phosphatidylethanolamine (POPE) mol-
ecules solvated with 5926 Martini water beads, yielding a
system size of 11,674 beads. The converted atomistic system
contains 126,028 atoms.
System 6LspA. The lipoprotein signal peptidase (LspA)
catalyzes the removal of signal peptides from prolipoproteins.
We used the Staphylococcus aureus model (PDB ID: 6RYO37)
to create the CG representation and for CG2AT2 conversion.
The system consists of a CG LspA, 74 POPG, and 290 POPE
molecules solvated with 7399 Martini water beads, producing a
system size of 12,928 beads. The system was converted to an
atomistic system of 142,690 atoms.
System 7Lnt. The lipoprotein N-acyl transferase (Lnt)
catalyzes the phospholipid-dependent N-acylation of the N-
terminal cysteine of apolipoproteins. We used the E. coli model
(PDB ID: 5N6H38) to create the CG representation and for
CG2AT2 conversion. The system consists of a CG Lnt with 75
POPG and 288 POPE molecules, solvated with 7840 Martini
water beads and a total system size of 14,091 beads. The
converted atomistic system has 153,299 atoms.
System 8LolB. This protein is an outer membrane
lipoprotein receptor and receives a mature lipoprotein from
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LolA for delivery to the outer membrane of Gram-negative
bacteria. We used the E. coli model (PDB ID: 1IWM39) to
create the CG representation and for CG2AT2 conversion.
The system consists of a CG LolB with 157 POPG and 363
POPE molecules solvated with 9736 Martini water beads with
a salt concentration of 0.15 M NaCl, yielding a system size of
17,529 beads. The atomistic system consists of 193,138 atoms.
System 9Kir2.2. Kir2.2 is an inward-rectifying potassium
channel. We used the Gallus gallus model (PDB ID: 3SPI40) to
create the CG representation and for CG2AT2 conversion.
The system consists of a CG tetrameric Kir2.2 with 4
phosphatidylinositol-4,5-bisphosphate (PIP2) and 465 POPC
molecules solvated with 14,960 Martini water beads with a
total system size of 24,272 beads. The atomistic system
contains 272,230 atoms.
System 10Wzm-Wzt. Wzm-Wzt transports fully elon-
gated, lipid-linked lipopolysaccharide (LPS) O-antigens across
the inner membrane, using an undecaprenyl-linked carrier. We
used the Aquifex aeolicus structure (PDB ID: 6M9641) to
create the CG representation and for CG2AT2 conversion.
The system consists of a CG tetrameric Wzm-Wzt with 125
POPG and 504 POPE molecules solvated with 18,661 Martini
water beads with therefore a system size of 28,938 beads. The
atomistic system contains 324,468 atoms.
System 11Lpt Complex. The LPS transport (Lpt)
protein complex spans the periplasm of Gram-negative bacteria
and shuttles LPS molecules from the inner to outer membrane.
We used E. coli structures and homology models (LptA:
2R19,42 LptC: 3MY2,43 LptB2FG: Swiss-model44 based on
6MIT,45 and LptDE: Swiss-model based on 4Q3546) to create
the CG representation and for CG2AT2 conversion. The
system consists of a CG Lpt complex composed of 4 LptA, 2
LptB, 1 LptC, 1 LptD, 1 LptE, 1 LptG, and 1 LptF with 147
LPSs, 284 POPG, and 1150 POPE molecules solvated with
133,459 Martini water beads with a total CG system size of
181,263 beads. The atomistic system has 2,039,940 atoms.
■ RESULTS
To assess the quality of the CG to atomistic conversion,
CG2AT2 was evaluated against 11 macromolecular systems of
varying size and complexity. To demonstrate the initial
accuracy, RMSDs were calculated for each de novo endpoint
against the input CG structure; this yielded excellent
conversion RMSDs of less than 0.09 nm. The RMSD between
the aligned structures to the CG demonstrates the fluctuations
of the CG structure over time. Therefore, the RMSD between
the aligned and supplied atomistic structures was measured.
This yielded RMSDs of less than 0.013 nm, within the range of
a standard minimized system. These results are summarized
within Table 1.
For CG2AT2 to be included in a workflow, the conversion
must ideally be undertaken in a high-throughput manner.
While the conversion time is highly dependent upon the
specifications of the machine used to run CG2AT2, we provide
a set of benchmarks as a guide for the user. Figure 3 shows the
cumulative time required for each step in the conversion with
the possible endpoints for the conversion shown. CG2AT2
takes roughly 4 min for a full conversion of a 100 K atom
system, producing an equilibrated de novo and aligned system.
As expected, the majority of the time to convert the system is
taken by the MD equilibration steps, namely, the NVT and the
multi-step steering.
Table 1. Similarities between the Martini Backbone and Cα Atom of Each Residue after End 1 and 2a
system protein monomers de novo vs CG de novo NVT + 100 ns sim aligned vs CG aligned vs input AT aligned + 100 ns sim
MIN NVT
SRY (3) 1 0.072 0.093 0.358 0.352 0.012 0.196
δ-opioid (4) 1 0.089 0.102 0.266 0.162 0.009 0.212
Lgt (5) 1 0.090 0.164 0.323 0.192 0.010 0.255
LspA (6) 1 0.088 0.150 0.293 0.159 0.011 0.230
Lnt (7) 1 0.088 0.127 0.183 0.098 0.010 0.198
LolB (8) 1 0.088 0.154 0.209 0.181 0.011 0.369
Kir2.2 (9) 4 0.087 0.105 0.386 0.152 0.010 0.261
WzmWzt (10) 4 0.087 0.147 0.329 0.187 0.013 0.225
Lpt (11) 11 0.090 0.217 n/a 0.305 0.011 n/a
aThe final RMSDs of the Cα atoms after 100 ns of atomistic simulation are reported in nm.
Figure 3. Timings for the conversion from CG to the CHARMM36 atomistic representation. The data show the cumulative time plotted against
the final atomistic size of each system. End 1 corresponds to the minimized de novo system, end 2 corresponds to the de novo after which a short
NVT simulation has been undertaken, end 3 corresponds to the production of the aligned structure without NVT equilibration, and end 4
corresponds to the production of the aligned structure with an NVT equilibration. The conversion was run on an i7-6800K Intel processor,
GeForce GTX 1080 GPU, and 64 Gb of RAM using GROMACS 2020 with the parallelization of CG2AT2 limited to 8 threads.
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Solvent. A significant update to CG2AT now allows for the
full conversion of the CG systems, including water molecules
and ions. Within the new implementation of solvent
conversion, CG2AT2 places a randomly rotated arrangement
of solvent molecules over each CG solvent bead. The solvent
fragment can contain any number of molecules in any
configuration. Here, we utilize a fragment containing four
water molecules in a roughly tetrahedral arrangement taken
from an equilibrated atomistic MD system. Additional solvent
molecules/models can easily be added as additional solvent
fragments. As CG ions are treated as solvated, the solvent
fragment is overlaid over the CG ion coordinate. This process
is demonstrated within Figure 4. The similarity of the CG to
AT solvent bulk properties is demonstrated in Figure 4B. Here,
we see similar density profiles in the complex membrane before
and after conversion. To assess the quality of the solvent
conversion, we analyzed the radial distribution function (RDF)
of the water oxygen atom against Na+, Cl−, and itself (Figure
4C). The quality of the initial solvent conversion is
demonstrated by the minimal shift in the peak RDF values
of less than 0.014 nm between initial minimization and
equilibrium values, demonstrating the need for minimal
equilibration after conversion.
Lipids. An advantage of converting CG simulations to
atomistic representation is the retention of the equilibrated
bilayer properties, such as the correctly mixed fluid-phase lipid
bilayer. We tested a conversion of a complex bilayer composed
of POPC, POPS, and CHOL at a ratio of 8:1:3 solvated with
0.15 M NaCl. An identical system was created by the
webserver CHARMM-GUI as a direct comparison.47 Both
systems were equilibrated for 1 ns in the NPT ensemble before
production runs. The area per lipid (APL) was compared
between the CG, CG2AT2, and CHARMM-GUI. Between the
CG2AT2 conversion and CHARMM-GUI membrane, the
APLs of the lipid components are in excellent agreement
(Figure S2A). We also calculated the lipid tail order parameter
profiles for the AT systems for both bilayers produced by
CG2AT2 and CHARMM-GUI (Figure S2B). After 100 ns, the
order parameters of both sets of simulations closely match.
Interestingly, however, the rate of convergence to the final
profile varies between the two methods, with CG2AT2
converging to a mean Δ-SCH at less than 0.005 roughly ∼25
ns faster than CHARMM-GUI (Figure S2C).
Assessing the Quality of the Conversion by Evaluat-
ing Protein Dynamics. We employed a set of nine protein
test systems, spanning a range of secondary structure
complexities and architectures. These systems were used to
evaluate the conversion procedure of CG2AT2 in terms of the
stability and quality of the dynamics over a subsequent 100 ns
of atomistic simulation after conversion. In all cases, the
majority of the secondary structure elements were recovered
from the CG simulations (Figure 5).
LolB was used to demonstrate the hybrid conversion
approach (Figure 2D). The β-barrel core of the LolB protein
was solved by X-ray crystallography; however, this lacks the N-
terminal region, which is anchored to the membrane by a
triacyl-cysteine. The N-terminal domain and the lipoprotein
tether were then grown onto the β-barrel in the CG
representation using the method outlined in Rao et al.23
To measure the similarity of the CG and the converted
systems, structures were compared using Cα and BB RMSDs.
A summary of conversion RMSDs is shown in Table 1.
Depending on the level of equilibration chosen, there is an
increasing degree of conformational drift. The de novo
conversion supplies a system closest to the initial CG
representation, with a post-minimization RMSD of 0.087 ±
0.005 nm compared to 0.140 ± 0.036 nm after NVT
equilibration. While a comparison between the aligned protein
structure and the CG model can be made, this mostly
highlights the deviation of the CG conformation from the
Figure 4. Solvent conversion. (A) Ion conversion; a tetrahedral arrangement of water is placed over a single ion located at the center of the CG ion
bead. A zoomed-out view of a Na+ ion surrounded by a cluster of CG water molecules. (B) Number density profiles of the complex membrane
system. Colors: system (blue), water and ions (orange), sterols (red), phospholipid tails (green), and the phospholipid headgroup (purple). (C) O,
Cl−, and Na+ atom RDFs referenced to the TIP3P oxygen atom. EM: complete system energy minimization by the steepest descent algorithm.
NVT: optional unrestrained 5 ps NVT equilibration. 1 ns MD: an initial 1 ns position-restrained NPT equilibration. 100 ns MD: a 100 ns NPT
production run.
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input atomistic structure. A more useful measurement is
between the aligned structure generated by the steered MD
step and the input atomistic structure. This typically provides
an RMSD of 0.011 ± 0.002 nm, highlighting that through
using the steered MD, the supplied structure can be accurately
reproduced. By applying variations in the aligned RMSD, any
clashes between aligned monomers and/or deviations arising
due to the hybridization method can be easily detected and
highlighted by CG2AT2 (0.015 nm cutoff).
The backbone provides much of the structural stability of
the protein. Therefore, we calculated a Ramachandran plot to
assess the stereochemical quality of the de novo and aligned
output of CG2AT2 (Figure S3). As a guide, a good atomic-
resolution protein model will generally provide over 90% of
residues within the allowed regions.48 Here, the de novo
conversion shows an excellent level of quality with 93−99%
within the allowed regions with the majority of the test systems
above 96%. This is also in excellent agreement to the aligned
structures, which were resolved at the atomic resolution.
While the RMSD and Ramachandran plots demonstrate the
accuracy and quality of the conversion, they provide little
information on the stability of the systems. Therefore, the
converted systems were simulated for 100 ns atomistic MD
simulations using the standard CHARMM36 force field
settings. The subsequent conformational drift of the protein
was analyzed by RMSD, root mean square fluctuation
(RMSF), and secondary structure retention (Table 1, Figure
5, Table S1 and Figure S4). In all cases, the structures
remained stable throughout the 100 ns simulation. The global
deviation of the simulations from their initial configuration is
highlighted by the RMSD. The de novo simulations
demonstrated a slightly larger degree of conformational drift
over the course of the simulation with an average RMSD of
0.293 ± 0.066 nm compared to 0.243 ± 0.052 nm for the
aligned systems. To pinpoint areas of instability and dynamic
regions of the converted system, we evaluated the RMSF
calculations. The nine test systems shown here demonstrate
comparable RMSFs to the aligned systems, with only the
extended loops and short helices showing values greater than
0.2 nm. This is most noticeable within the periplasmic region
of Lgt and the N- and C-terminal regions of Kir2.2.
While the tertiary and secondary structures within the
Martini simulations are retained via the use of elastic networks,
minor changes can still occur within the protein structure. We
therefore expect to see the majority of the secondary structure
to be recovered during the de novo conversion, as detailed in
the original atomistic protein coordinate file. A qualitative
comparison of the secondary structures in Figure 5
demonstrates that a large degree of the secondary structure
is recovered and retained over the 100 ns simulation. There are
also only minor variations in the secondary structure retention,
when using the de novo approach, and this is in excellent
agreement with the aligned systems. This is further highlighted
by the Jaccard indices, which measure the similarity between
two sets of data ranging from uncorrelated (0) to correlated
(1). Representing the secondary structure correlation to a
reference structure, the numbers presented here represent the
mean of the simulations. The aligned structures were used as a
guide to estimate the secondary structure variability over 100
ns of atomistic simulation, with a mean index of 0.81 ± 0.07. A
Jaccard index was calculated for the de novo conversion in
relation to the input structure to test the ability of CG2AT2 to
recover the original secondary structure, with a mean index of
0.69 ± 0.09. A Jaccard index of 0.72 ± 0.07 was also calculated
to compare the de novo simulation to the de novo starting
structure. These values demonstrate that the dynamics of the
de novo conversion are marginally higher than those of the
aligned systems. This appears to arise from drift in the β-
strands within the CG system. Recovery of short helices can be
seen in Figure 5, in particular the LspA and Lgt de novo
conversions.
Protein−Ligand Interactions. Two of the core advan-
tages of CG simulations are straightforward system config-
uration, for example, insane and quick equilibration. A number
of papers have demonstrated the use of CG simulations to find
difficult small-molecule ligand coordination sites, lipid binding
sites, and protein−protein interactions.49 Here, we demon-
strate the conversion of the tetrameric Kir2.2 protein
coordinated with PIP2 lipids. To generate a Kir2.2:PIP2
binding pose, the system was simulated for 1 μs. The final
frame from the CG simulation captured two bound PIP2
molecules, as described previously (Corey et al.7). We show
qualitatively that the steering process to generate the aligned
systems minimally perturbs the binding pattern between the
lipid and the protein (Figure 6). The RMSDs between the de
novo and aligned PIP2 non-hydrogen atoms shown in binding
sites 1 and 2 are 0.25 and 0.29 nm, respectively.
Figure 5. Protein secondary structure and stability. Original supplied
structures from the RCSB database (SSi). The protein structure after
initial conversion color by the secondary structure (SSe). The protein
secondary structure after 100 ns of atomistic simulation, colored by
the end secondary structure (RMSF). The protein structure after 100
ns colored by the RMSF, on a blue to red scale, with each monomer
aligned individually. The color scheme used for the secondary
structure is as follows. Turn: cyan, extended sheet: orange, bridge: tan,
α-helix: lime, 310-helix: purple, π-helix: blue, and coil: silver.
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The increased RMSD arises from the inevitable rearrange-
ment of amino acids, leading to small steric clashes and
rearrangement of electrostatic interactions between the aligned
protein and PIP2. To test the stability of the PIP2 binding pose,
the lipid contact maps of the converted systems were
compared to those of the CG system. To provide a comparable
map, the contacts within the last 100 ns of the CG simulation
were compared to those of the 100 ns atomistic simulation. As
shown by Figure 6, the contact maps between the three
simulations are near-identical, demonstrating the preservation
of the protein−ligand interface. The Pearson correlation
coefficient between the converted atomistic simulations and
the CG simulation provides values of 0.71 and 0.70 for the de
novo and aligned systems, respectively. The high correlation of
0.77 between the de novo and aligned systems demonstrates
that little modification has occurred to the protein−PIP2
interactions as a result of the steered MD alignment.
Another complex system conversion problem is protein
complexes that contain DNA. Here, we demonstrate the
variability of CG2AT2 with the conversion of the SRY protein
in a complex with 14 base pairs of double-stranded DNA
(Figure 6B). The multimeric non-protein residues are
converted in a similar manner through the protein de novo
conversion with the exception of the further processing of the
protein backbone. To analyze the stability of the protein−
DNA complex over the course of the simulations, the number
of DNA interchain hydrogen bonds was calculated. We show
in Figure 6B that the hydrogen bonding pattern remains stable
in both de novo and aligned atomistic simulations with the total
number of H-bonds being 29.0 ± 3.0 and 26.3 ± 2.5,
respectively.
■ DISCUSSION
We have described an updated fragment-based approach of
CG2AT for the accurate conversion of complex CG
representations to atomistic details. Here, we have demon-
strated against a variety of systems that CG2AT2 can provide a
gradient of conversion approaches from completely de novo to
aligned, depending upon the degree of protein conformational
changes in the CG system the user wishes to retain. A graphical
representation of the workflow of CG2AT is demonstrated by
the multi-component CG Lpt system, composed of 11 protein
monomers and 2 lipid bilayers (1434 lipids and 147 LPS)
(Figure 7).
CG2AT2 now performs complete reconstruction of atom-
istic systems from CG, including water. This is achieved almost
entirely within the python-based code, with GROMACS called
to generate topologies and to run the equilibration simulations.
CG2AT2 can convert complete systems with no pre-processing
of the input files, via a supplied comprehensive database of
over 107 unique residue types, at the time of publication. The
current individual fragment libraries include standard
CHARMM36, CHARMM36 with virtual sites, and Stockholm
lipids (Slipids)50 for conversion from CG Martini versions 2
and 3. To enable the variability of the residue types, we have
included a range of updated force fields (AMBER99SB-ILDN
with Slipids and CHARMM36) containing additional param-
eters and the base-level force fields. However, it should be
noted that all GROMACS-readable force fields are compatible
with CG2AT2.
The protocol outlined here generates the key files required
for a production run simulation including an equilibrated
atomistic system and topology files. This enables the user to
implement high-throughput robust and accurate conversion of
CG systems with minimal further processing. In combination
with tools such as TS2CG,51 CG2AT2 may enable the
conversion of triangulated surfaces all the way down to the full
atomic-level detail and thereby permit flexible approaches for
converting between molecular systems at multiple levels of
granularity.
■ AVAILABILITY
CG2AT2 is available from github, https://github.com/
owenvickery/cg2at, and may be added to a Conda installation
Figure 6. Protein/ligand conversion and retention. (A) Conversion of the Kir2.2 bound to four PIP2 lipids. Shown here are two PIP2 lipids bound
in pose 1 and 2. The PIP2 binding sites found in the CG simulations are retained upon both de novo and aligned conversions. (Bottom right) The
contact maps of PIP2 binding to Kir2.2. The last 100 ns of the CG simulation is shown as a comparison with the 100 ns atomistic simulations. (B)
Conversion of the SRY protein in complex with double-stranded DNA. The number of DNA interchain hydrogen bonds over the 100 ns is shown;
the dotted line highlights the starting number of hydrogen bonds.
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using conda install -c stansfeld_rg cg2at. For full usage
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Plots from atomistic MD simulation for both protein
and lipids after conversion detailing the structural
stability of the converted protein and the dynamic
properties of the lipids (PDF)
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